SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: BoredMember who wrote (9528)12/26/2017 11:02:13 AM
From: KMBJN.  Read Replies (1) | Respond to of 12873
 
Ha, thanks for the kind response, and for confirming things.

You are welcome for the simplistic techno-babble.

What did you think of the paper? Did you read it?
What are the similarities and differences of the two technologies?

Best Regards



To: BoredMember who wrote (9528)12/26/2017 7:28:13 PM
From: HardToFind  Read Replies (1) | Respond to of 12873
 
Some people just can’t accept that Nanoviricides are the world’s next penicillin.
The analogy between nanoviricides and penicillin is far from perfect, but I think most people on this board respect the capabilities of the technology.

The bigger question is: "Will WE ever get paid for investing in NNVC? On that matter, the jury's still out.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News